Issue 6/2019
Content (16 Articles)
Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients
Véronique Quillien, Antoine F. Carpentier, Alain Gey, Tony Avril, Eric Tartour, Floraly Sejalon, Boris Campillo-Gimenez, Elodie Vauleon
HCT-116 colorectal cancer cells secrete chemokines which induce chemoattraction and intracellular calcium mobilization in NK92 cells
Noha Mousaad Elemam, Zaidoon Al-Jaderi, Mahmood Yaseen Hachim, Azzam A. Maghazachi
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition
Vylyny Chat, Robert Ferguson, Danny Simpson, Esther Kazlow, Rebecca Lax, Una Moran, Anna Pavlick, Dennie Frederick, Genevieve Boland, Ryan Sullivan, Antoni Ribas, Keith Flaherty, Iman Osman, Jeffrey Weber, Tomas Kirchhoff
DNA lesions correlate with lymphocyte function after selective internal radiotherapy
Aglaia Domouchtsidou, Vahé Barsegian, Stefan P. Mueller, Pavel Lobachevsky, Jan Best, Peter A. Horn, Andreas Bockisch, Monika Lindemann
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer
Kenneth L. Kehl, Shihao Yang, Mark M. Awad, Nathan Palmer, Isaac S. Kohane, Deborah Schrag
An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma
Panagiotis Tsagozis, Martin Augsten, Yifan Zhang, Tian Li, Asle Hesla, Jonas Bergh, Felix Haglund, Nicholas P. Tobin, Monika Ehnman
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma
Kim C. M. Santegoets, Paul R. Gielen, Christian Büll, Barbara M. Schulte, Esther D. Kers-Rebel, Benno Küsters, Sandra A. J. F. H. Bossman, Mark ter Laan, Pieter Wesseling, Gosse J. Adema
Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas
Lucie Duverger, Amélie Osio, Bernard Cribier, Laurent Mortier, Adèle De Masson, Nicole Basset-Seguin, Céleste Lebbé, Maxime Battistella
Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model
Ming Chen, Min Xu, Chengliang Zhu, Hongling Wang, Qiu Zhao, Feng Zhou
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy
Sebastian Klein, Cornelia Mauch, Svenja Wagener-Ryczek, Maximilian Schoemmel, Reinhard Buettner, Alexander Quaas, Doris Helbig
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series
Selma Ugurel, Ivelina Spassova, Jonas Wohlfarth, Christina Drusio, Angela Cherouny, Anita Melior, Antje Sucker, Lisa Zimmer, Cathrin Ritter, Dirk Schadendorf, Jürgen C. Becker
Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
Bradley C. Holland, Akshay Sood, Kristin Delfino, Danuta I. Dynda, Sophia Ran, Natalie Freed, Shaheen Alanee
Systemic and local immunosuppression in patients with high-grade meningiomas
Yuping D. Li, Dorina Veliceasa, Jason B. Lamano, Jonathan B. Lamano, Gurvinder Kaur, Dauren Biyashev, Craig M. Horbinski, Tim J. Kruser, Orin Bloch
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile
Daniëlle Krijgsman, Natasja L. de Vries, Anni Skovbo, Morten N. Andersen, Marloes Swets, Esther Bastiaannet, Alexander L. Vahrmeijer, Cornelis J. H. van de Velde, Mirjam H. M. Heemskerk, Marianne Hokland, Peter J. K. Kuppen
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
Bas D. Koster, Saskia J. A. M. Santegoets, Jorien Harting, Arnold Baars, S. Marieke van Ham, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl, Alfons J. M. van den Eertwegh
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
Bas D. Koster, Saskia J. A. M. Santegoets, Jorien Harting, Arnold Baars, S. Marieke van Ham, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl, Alfons J. M. van den Eertwegh